PSGL-1缺陷小鼠自发系统性硬化症相关肺动脉高压
该研究在PSGL-1缺陷小鼠中观察自发性系统性硬化症(SSc)样综合征是否伴随肺动脉高压(PAH)。结果显示老年雌性PSGL-1-/-小鼠出现肺血管重构、内皮功能障碍、肺内血管紧张素II升高、eNOS磷酸化降低及调节性T细胞减少,33%的老年雌性小鼠出现肺动脉加速时间与射血时间比值降低,提示PAH。
要点
- PSGL-1缺陷小鼠自发SSc样综合征并出现肺血管重构和内皮功能障碍。
- 老年雌性PSGL-1-/-小鼠肺内Ang II升高、AT2R表达降低、eNOS磷酸化减少。
- 33%老年雌性PSGL-1-/-小鼠肺动脉加速时间与射血时间比值降低提示PAH。
核心结论
- PSGL-1缺失导致调节性T细胞减少、NO产生减少、ERα表达降低及肺内Ang II升高,促进雌性小鼠PAH发生。
研究设计与样本
- 使用PSGL-1缺陷小鼠(PSGL-1-/-)作为自发性SSc样综合征模型,每组4-8只小鼠。
- 采用多普勒超声心动图估测肺动脉压力,免疫组化评估血管重构,离体肺动脉环肌动描记分析血管反应性。
- 通过ELISA定量Ang II,Western blot检测AT1R、AT2R、eNOS及磷酸化eNOS表达,流式细胞术检测免疫细胞因子和内皮细胞NO产生。
主要发现
- PSGL-1-/-小鼠出现肺血管壁重构,且肺内AT2R表达降低(雌性>18月龄:野生型0.799±0.508 vs 敲除型0.346±0.229,表达比值相对β-actin)。
- 老年雌性PSGL-1-/-小鼠ERα上调受损,肺血管内皮功能障碍,肺内Ang II升高(野生型48.70±5.13 pg/gm肺组织 vs 敲除型78.02±28.09 pg/gm肺组织),eNOS磷酸化降低,内皮NO产生减少。
- 33%老年雌性PSGL-1-/-小鼠肺动脉加速时间与射血时间比值降低,提示肺动脉高压。
- PSGL-1-/-小鼠中产生干扰素-γ的T细胞和B细胞群体扩增,调节性T细胞减少。
临床怎么用
- PSGL-1缺陷小鼠可作为研究SSc相关PAH发病机制的模型,尤其关注雌性老年小鼠。
- 肺内Ang II升高、AT2R降低、eNOS磷酸化减少及Treg减少可能作为PAH发生的机制标志。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Pulmonary arterial hypertension (PAH), one of the major complications of systemic sclerosis (SSc), is a rare disease with unknown etiopathogenesis and noncurative treatments. As mice deficient in P-selectin glycoprotein ligand 1 (PSGL-1) develop a spontaneous SSc-like syndrome, we undertook this study to analyze whether they develop PAH and to examine the molecular mechanisms involved. METHODS: Doppler echocardiography was used to estimate pulmonary pressure, immunohistochemistry was used to assess vascular remodeling, and myography of dissected pulmonary artery rings was used to analyze vascular reactivity. Angiotensin II (Ang II) levels were quantified by enzyme-linked immunosorbent assay, and Western blotting was used to measure Ang II type 1 receptor (AT1 R), AT2 R, endothelial cell nitric oxide synthase (eNOS), and phosphorylated eNOS expression in lung lysates. Flow cytometry allowed us to determine cytokine production by immune cells and NO production by endothelial cells. In all cases, there were 4-8 mice per experimental group. RESULTS: PSGL-1-/- mice showed lung vessel wall remodeling and a reduced mean ± SD expression of pulmonary AT2 R (expression ratio [relative to β-actin] in female mice age >18 months: wild-type mice 0.799 ± 0.508 versus knockout mice 0.346 ± 0.229). With aging, female PSGL-1-/- mice had impaired up-regulation of estrogen receptor α (ERα) and developed lung vascular endothelial dysfunction coinciding with an increase in mean ± SEM pulmonary Ang II levels (wild-type 48.70 ± 5.13 pg/gm lung tissue versus knockout 78.02 ± 28.09 pg/gm lung tissue) and a decrease in eNOS phosphorylation, leading to reduced endothelial NO production. These events led to a reduction in the pulmonary artery acceleration time:ejection time ratio in 33% of aged female PSGL-1-/- mice, indicating pulmonary hypertension. Importantly, we found expanded populations of interferon-γ-producing PSGL-1-/- T cells and B cells and a reduced presence of regulatory T cells. CONCLUSION: The absence of PSGL-1 induces a reduction in Treg cells, NO production, and ERα expression and causes an increase in Ang II in the lungs of female mice, favoring the development of PAH.
引用
- González-Tajuelo R, de la Fuente-Fernández M, Morales-Cano D, et al. Spontaneous Pulmonary Hypertension Associated With Systemic Sclerosis in P-Selectin Glycoprotein Ligand 1-Deficient Mice. Arthritis Rheumatol. 2020. PMID: 31509349. doi:10.1002/art.41100
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。